Myriad Genetics Inc (MYGN)
15.12
-0.18
(-1.18%)
USD |
NASDAQ |
Nov 21, 16:00
15.12
0.00 (0.00%)
After-Hours: 20:00
Myriad Genetics Enterprise Value: 1.316B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
November 21, 2024 | 1.316B |
November 20, 2024 | 1.332B |
November 19, 2024 | 1.305B |
November 18, 2024 | 1.325B |
November 15, 2024 | 1.327B |
November 14, 2024 | 1.367B |
November 13, 2024 | 1.376B |
November 12, 2024 | 1.411B |
November 11, 2024 | 1.515B |
November 08, 2024 | 1.524B |
November 07, 2024 | 1.548B |
November 06, 2024 | 1.539B |
November 05, 2024 | 1.542B |
November 04, 2024 | 1.562B |
November 01, 2024 | 1.576B |
October 31, 2024 | 1.937B |
October 30, 2024 | 2.011B |
October 29, 2024 | 1.966B |
October 28, 2024 | 1.937B |
October 25, 2024 | 1.901B |
October 24, 2024 | 1.924B |
October 23, 2024 | 1.970B |
October 22, 2024 | 1.998B |
October 21, 2024 | 1.990B |
October 18, 2024 | 2.068B |
Date | Value |
---|---|
October 17, 2024 | 2.062B |
October 16, 2024 | 2.116B |
October 15, 2024 | 2.121B |
October 14, 2024 | 2.223B |
October 11, 2024 | 2.130B |
October 10, 2024 | 2.038B |
October 09, 2024 | 2.157B |
October 08, 2024 | 2.301B |
October 07, 2024 | 2.318B |
October 04, 2024 | 2.348B |
October 03, 2024 | 2.344B |
October 02, 2024 | 2.392B |
October 01, 2024 | 2.399B |
September 30, 2024 | 2.432B |
September 27, 2024 | 2.345B |
September 26, 2024 | 2.324B |
September 25, 2024 | 2.311B |
September 24, 2024 | 2.353B |
September 23, 2024 | 2.387B |
September 20, 2024 | 2.452B |
September 19, 2024 | 2.511B |
September 18, 2024 | 2.527B |
September 17, 2024 | 2.539B |
September 16, 2024 | 2.475B |
September 13, 2024 | 2.447B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
812.70M
Minimum
Mar 18 2020
2.801B
Maximum
Sep 01 2021
1.708B
Average
1.703B
Median
Mar 30 2022
Enterprise Value Benchmarks
Boston Scientific Corp | 143.48B |
ResMed Inc | 36.01B |
Globus Medical Inc | 11.30B |
Perspective Therapeutics Inc | -63.40M |
Electromed Inc | 223.55M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -22.10M |
Revenue (Quarterly) | 213.30M |
Total Expenses (Quarterly) | 231.10M |
EPS Diluted (Quarterly) | -0.24 |
Gross Profit Margin (Quarterly) | 70.23% |
Profit Margin (Quarterly) | -10.36% |
Earnings Yield | -8.60% |
Normalized Earnings Yield | -7.562 |